These HIV Phase II trials have been designed in coordination with BP & Board of experts in the HIV field to obtain the data required. Any negotiations will be a continuation from extensive talks from prior results. Covid will be key to demonstrating broad spectrum direct acting antiviral activity in humans and may put a spanner in the works when it comes to prior extensive negotiations.
Also please name a Biotech on ASX who entitled to and not claiming R&D tax offset?
These HIV Phase II trials have been designed in coordination...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.001(1.89%) |
Mkt cap ! $48.72M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $6.98K | 133.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 151165 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 86242 | 1 |
View Market Depth
| Last trade - 15.32pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.2¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.3¢ | 5.3¢ | 5.2¢ | 38302 | ||
| Last updated 11.25am 24/05/2024 ? | |||||
| BIT (ASX) Chart |